Icariin increases the proportion of tumor-infiltrating CD4+ and CD8+ T cells, reduces the number of MDSCs, and induces their differentiation into macrophages and DCs, restores CD8+ T cell function in 4T1 breast cancer xenograft model in vivo [697, 706]. The gene discussed is CD4; the disease is neoplasm.